Related Experiment Videos
Thromboembolism and the role of anticoagulation in the Fontan patient
1Section of Cardiothoracic Surgery, St. Christopher's Hospital for Children, Erie Avenue at Front Street, Philadelphia, PA 19134, USA. Marshall.Jacobs@tenethealth.com
Insights
Thromboembolic complications are a major cause of morbidity and failure in Fontan circulation. Addressing this complex issue likely requires a multifaceted approach rather than a single solution.
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Hematology
Background:
- Thromboembolic complications significantly contribute to morbidity and Fontan circulation failure.
- Potential causes include low flow, venous stasis, shunts, prosthetic materials, arrhythmias, and hypercoagulable states.
Purpose of the Study:
- To review and characterize thromboembolic events following Fontan operations.
- To identify patient, surgical, hemodynamic, and hematologic factors associated with thromboembolic risk.
- To examine current prophylactic anticoagulation strategies.
Main Methods:
- Literature review of retrospective investigations.
- Analysis of factors contributing to thromboembolism.
- Assessment of varying anticoagulation practices.
Main Results:
- Thromboembolic events are multifactorial, arising from complex biologic interactions.
- Risk factors are diverse, encompassing patient-specific and surgical elements.
- Current prophylactic strategies show wide variation.
Conclusions:
- Thromboembolism after Fontan operations is a complex problem with multiple interacting factors.
- A single therapeutic agent is unlikely to resolve this issue.
- Further research into integrated management strategies is warranted.
Abstract:
Among factors contributing to morbidity and failure of the Fontan circulation is the group of events referred to as thromboembolic complications. These events have been variously attributed to low flow states, stasis in the venous pathways, right-to-left shunts, blind cul-de-sacs, prosthetic material, atrial arrhythmias, and hypercoagulable states. Numerous investigations, most retrospective, have been undertaken to characterize thromboembolic events; describe the frequency and circumstances of these occurrences; and relate the risk of these events to patient, surgical, hemodynamic, and hematologic factors. Practices vary widely with respect to strategies of prophylactic anticoagulation in the hopes of minimizing the occurrence and morbidity of thromboembolism after Fontan operations. Review of the literature suggests that the factors associated with thromboembolic events after Fontan operations likely represent a complex field of biologic factors with multiple interactions. It is unlikely that a single agent will represent the solution to this complex problem.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism III: Nursing Management
Venous Thrombosis I: Introduction